πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 389 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8163542

Potent combinations of mRNA transport elements

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8158603

Fragments of secreted frizzled related protein

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Apr 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8148323

Method of treating or inhibiting inflammation by multi-domain amphipathic helical peptides

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8143252

Tetrahalogenated compounds useful as inhibitors of angiogenesis

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8129351

Immunostimulatory nucleic acid molecules

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Mar 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8119642

Structurally rigid dopamine D3 receptor selective ligands and process for making them

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8114406

Peptides and their utility in modulation of behavior of cells expressing Ξ±3Ξ²1 integrins

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8106026

Development of a preventive vaccine for filovirus infection in primates

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8106006

Modified defensins and their use

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8105609

Flavivirus immunogens comprising extracellular viral particles composed of the premembrane

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8105598

Human monoclonal antibodies that specifically bind IGF-II

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8092809

Pseudomonas exotoxin A-like chimeric immunogens

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8084415

Uteroglobin in the treatment of IGA mediated nephropathy

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8084250

Defensin-antigen fusion proteins

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8080554

Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Dec 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8075921

Rapamycin-resistant T cells and therapeutic uses thereof

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8071323

Human monoclonal antibodies that bind human insulin like growth factors and their use

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8067563

Tumor suppressor gene, p471NG3

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8058249

Immunostimulatory nucleic acid molecules

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8048432

Polysaccharide-protein conjugate vaccines

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8044185

Conformationally stabilized HIV envelope immunogens and triggering HIV-I envelope to revea

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8044057

Methods for suppressing an immune response or treating a proliferative disorder

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8043622

Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8038997

Anti-marinobufagenin antibodies and methods for their use

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted